3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Gastrointestinal
1
Conditions
Stomach Neoplasms
15
Colorectal Neoplasms
15
Pancreatic Neoplasms
11
Colonic Neoplasms
9
Carcinoma, Hepatocellular
9
Esophageal Neoplasms
6
Rectal Neoplasms
5
Colorectal Neoplasms, Hereditary Nonpolyposis
4
Anus Neoplasms
4
Neoplasms
3
Gastrointestinal Stromal Tumors
3
Gastrointestinal Neoplasms
3
Gallbladder Neoplasms
3
Vulvar Neoplasms
2
Uterine Cervical Neoplasms
2
Squamous Intraepithelial Lesions
2
Peritoneal Neoplasms
2
Ovarian Neoplasms
2
Melanoma
2
Endometrial Neoplasms
2
Cholangiocarcinoma
2
Bile Duct Neoplasms
2
Acquired Immunodeficiency Syndrome
2
Vaginal Neoplasms
1
Urinary Bladder Neoplasms
1
Skin Neoplasms
1
Recurrence
1
Pseudomyxoma Peritonei
1
Prostatic Neoplasms
1
Papillomavirus Infections
1
Interventions
Vaccines
3
Papillomavirus Vaccines
3
Watchful Waiting
2
Light Coagulation
2
fludarabine phosphate
1
fludarabine
1
aldesleukin
1
Papanicolaou Test
1
Observation
1
Laser Therapy
1
Imiquimod
1
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
1
Fluorouracil
1
Cytological Techniques
1
Cyclophosphamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Papillomavirus Infections
×
Observation
×
Gastrointestinal
×
Clear all
NCT02135419
2024-07-26
ANCHOR
AIDS Malignancy Consortium
Phase 3
Completed
4,446 enrolled
13 charts